TickerFacts.

Indaptus Therapeutics, Inc. (INDP): Net Income

Annual figures by period end, from SEC filings.

-$20.85M
Year ended 2025-12-31
-$15.42M
Trailing 12 months to 2026-06-30
2020-12-31: -$3.58M2021-12-31: -$7.71M2022-12-31: -$14.32M2023-12-31: -$15.42M2024-12-31: -$15.02M2025-12-31: -$20.85M-$20.85M
2020-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$20.85Mn/m2026-03-17, From 2025-01-01
2024-12-31-$15.02Mn/m2026-03-17, From 2024-01-01
2023-12-31-$15.42Mn/m2025-03-13, From 2023-01-01
2022-12-31-$14.32Mn/m2024-03-13, From 2022-01-01
2021-12-31-$7.71Mn/m2023-03-17, From 2021-01-01
2020-12-31-$3.58Mn/a2022-03-21, From 2020-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Indaptus Therapeutics, Inc. (INDP)2025-12-31-$20.85Mn/m
Soligenix, Inc. (SNGX)2025-12-31-$11.08Mn/m
ProMIS Neurosciences Inc. (PMN)2025-12-31-$39.72Mn/m
Kala Bio, Inc. (KALA)2025-12-31-$26.98Mn/m
Can-Fite BioPharma Ltd. (CANF)2025-12-31-$9.83Mn/m
FibroBiologics, Inc. (FBLG)2025-12-31-$18.65Mn/m
Earth Science Tech, Inc. (ETST)2026-03-31$3.63M+11.6%
MAIA Biotechnology, Inc. (MAIA)2025-12-31-$22.40Mn/m
Cocrystal Pharma, Inc. (COCP)2025-12-31-$8.83Mn/m

Compare INDP, SNGX, PMN, KALA side by side · Screen every company in Pharmaceutical Preparations ↗